FT : What BioNTech did next: the plan for a revolution in cancer care What BioNTech did next: the plan for a revolution in cancer careThe German company is ploughing Covid vaccine profits into oncology but its technology is still largely unproven Download What_BioNTech_did_next__the_plan_for_a_revolution_in_cancer_care___Financial_Times.pdf